Men and women often experience similar bladder symptoms, but the causes are completely different. With insights from Dr ...
Urinary incontinence affects millions globally. It is an uncontrolled release of urine. Causes include aging, obesity, and ...
HealthShots on MSN
Urologist says men shouldn’t ignore these 5 common symptoms of prostate enlargement
Prostate health is important for men of all ages, not just older men. Women should also encourage the men in their lives, ...
And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...
ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...
Most women begin the menopausal transition in their 40s and 50s, but some can have symptoms in their 30s. Mayo Clinic doctors ...
The Uganda Cancer Institute (UCI) has sounded an urgent warning over a sharp rise in prostate cancer cases, now the most commonly diagnosed cancer among men in the country and a leading cause of ...
Investigators reported 1-year disease-free survival results from patients with BCG-unresponsive papillary disease-only high-risk NMIBC in the phase 2b SunRISe-1 trial.
The FDA has approved GSK's gepotidacin (Blujepa), the first new antibiotic class for gonorrhea in over three decades, ...
US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...
A groundbreaking trial for a prostate cancer treatment has been launched in the UK, with the hope of reducing the side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback